ATE348839T1 - Acylierte betulin- und dihydrobetulinderivate, ihre herstellung und verwendung - Google Patents
Acylierte betulin- und dihydrobetulinderivate, ihre herstellung und verwendungInfo
- Publication number
- ATE348839T1 ATE348839T1 AT99909758T AT99909758T ATE348839T1 AT E348839 T1 ATE348839 T1 AT E348839T1 AT 99909758 T AT99909758 T AT 99909758T AT 99909758 T AT99909758 T AT 99909758T AT E348839 T1 ATE348839 T1 AT E348839T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted
- preparation
- betulin
- dihydrobetulin
- hydrogen
- Prior art date
Links
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical class C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 title abstract 2
- JZZMDHQYBFQRMW-ROUWMTJPSA-N (1s,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-propan-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol Chemical class C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C JZZMDHQYBFQRMW-ROUWMTJPSA-N 0.000 title 1
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 abstract 1
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 abstract 1
- 230000036436 anti-hiv Effects 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7644998P | 1998-03-02 | 1998-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE348839T1 true ATE348839T1 (de) | 2007-01-15 |
Family
ID=22132095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99909758T ATE348839T1 (de) | 1998-03-02 | 1999-03-02 | Acylierte betulin- und dihydrobetulinderivate, ihre herstellung und verwendung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6172110B1 (enExample) |
| EP (1) | EP1068219B1 (enExample) |
| JP (1) | JP2002505337A (enExample) |
| AT (1) | ATE348839T1 (enExample) |
| AU (1) | AU762404B2 (enExample) |
| CA (1) | CA2322868C (enExample) |
| DE (1) | DE69934486T2 (enExample) |
| DK (1) | DK1068219T3 (enExample) |
| ES (1) | ES2281960T3 (enExample) |
| NZ (1) | NZ506623A (enExample) |
| PT (1) | PT1068219E (enExample) |
| WO (1) | WO1999045025A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6232481B1 (en) * | 2000-01-11 | 2001-05-15 | Regents Of The University Of Minnesota | Method for manufacturing betulinic acid |
| US6656970B2 (en) * | 2000-05-11 | 2003-12-02 | Dabur Research Foundation | Method and compositions for solubilization of pentacyclic triterpenes |
| US7365221B2 (en) * | 2002-09-26 | 2008-04-29 | Panacos Pharmaceuticals, Inc. | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| WO2004028455A2 (en) * | 2002-09-26 | 2004-04-08 | Panacos Pharmaceuticals, Inc. | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| AU2004210162A1 (en) * | 2003-01-29 | 2004-08-19 | Panacos Pharmaceuticals, Inc. | Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| US7537765B2 (en) * | 2003-01-29 | 2009-05-26 | Panacos Pharmaceuticals, Inc. | Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| US7026305B2 (en) * | 2003-04-14 | 2006-04-11 | Meharry Medical College | Anti-HIV agents with dual sites of action |
| EP1730163A4 (en) * | 2004-03-17 | 2009-12-30 | Panacos Pharmaceuticals Inc | Pharmaceutical salts of 3-O- (3,3-dimethylsuccinyl) betulinic acid |
| US20050215544A1 (en) * | 2004-03-24 | 2005-09-29 | Pin-Fang Lin | Methods of treating HIV infection |
| US7776863B2 (en) * | 2004-03-24 | 2010-08-17 | Bristol-Myers Squibb Company | Methods of treating HIV infection |
| WO2005112929A2 (en) * | 2004-05-20 | 2005-12-01 | Cornell Research Foundation, Inc. | Anti-hiv-1 activity of betulinol derivatives |
| US7282521B2 (en) * | 2004-05-24 | 2007-10-16 | University Of North Carolina At Chapel Hill | Anti-retroviral moronic acid derivatives |
| US8008280B2 (en) * | 2004-09-10 | 2011-08-30 | Biorings Llc | Betulinol derivatives as anti-HIV agents |
| TW200628161A (en) * | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
| BRPI0610668A2 (pt) * | 2005-04-12 | 2010-07-13 | Panacos Pharmaceuticals Inc | polimorfas de di-n-metil-d-glucamina do ácido 3-o-(3',3'-dimetilsuccinil) betulìnico |
| FI121468B (fi) * | 2006-06-07 | 2010-11-30 | Valtion Teknillinen | Betuliiniperäiset yhdisteet antimikrobisina aineina |
| US20080039428A1 (en) * | 2006-06-29 | 2008-02-14 | Panacos Pharmaceuticals, Inc. | Antiretroviral combination therapy |
| WO2008057420A2 (en) | 2006-11-03 | 2008-05-15 | Panacos Pharmaceuticals, Inc. | Extended triterpene derivatives |
| US20110152229A1 (en) * | 2006-11-22 | 2011-06-23 | Duke University | Betulinic acid derivatives as anti-hiv agents |
| US8269026B2 (en) * | 2008-01-03 | 2012-09-18 | Vertex Pharmaceuticals Incorporated | Lupane derivatives useful for treating HIV |
| KR100941595B1 (ko) * | 2008-06-05 | 2010-02-11 | 주식회사 알앤엘바이오 | 바이러스 억제제로서 유용한 트리테르페노이드계 화합물 |
| US20100104669A1 (en) * | 2008-10-28 | 2010-04-29 | Scheffler Armin | Method for preparing an aqueous solution containing triterpenic acid, aqueous solution containing triterpenic acid, and use thereof |
| BR112012030810A2 (pt) * | 2010-06-04 | 2019-09-24 | Bristol-Myers Squibb Company | "c-28 amidas de derivados de ácido c-3 betulínico modificados como inibidores de maturação de hiv" |
| CA2801487C (en) * | 2010-06-04 | 2017-12-05 | Bristol-Myers Squibb Company | Modified c-3 betulinic acid derivatives as hiv maturation inhibitors |
| RU2496785C1 (ru) * | 2012-09-24 | 2013-10-27 | Федеральное государственное бюджетное учреждение науки Институт технической химии Уральского отделения Российской академии наук (ИТХ УрО РАН) | Тритерпеноиды с фрагментом ен-нитрила в а-пентацикле |
| PL227790B1 (pl) | 2015-08-13 | 2018-01-31 | Slaski Univ Medyczny W Katowicach | Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie. |
| PL237998B1 (pl) | 2018-05-28 | 2021-06-28 | Narodowy Inst Lekow | Fosfonowe pochodne kwasu 3-karboksyacylobetulinowego, sposób ich otrzymywania oraz ich zastosowanie |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01143832A (ja) * | 1987-12-01 | 1989-06-06 | Toa Nenryo Kogyo Kk | 制癌剤 |
| FR2683531B1 (fr) * | 1991-11-13 | 1993-12-31 | Rhone Poulenc Rorer Sa | Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent. |
| US5679828A (en) * | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
-
1999
- 1999-03-02 NZ NZ506623A patent/NZ506623A/xx unknown
- 1999-03-02 AT AT99909758T patent/ATE348839T1/de not_active IP Right Cessation
- 1999-03-02 DE DE69934486T patent/DE69934486T2/de not_active Expired - Fee Related
- 1999-03-02 CA CA002322868A patent/CA2322868C/en not_active Expired - Fee Related
- 1999-03-02 JP JP2000534567A patent/JP2002505337A/ja active Pending
- 1999-03-02 PT PT99909758T patent/PT1068219E/pt unknown
- 1999-03-02 DK DK99909758T patent/DK1068219T3/da active
- 1999-03-02 EP EP99909758A patent/EP1068219B1/en not_active Expired - Lifetime
- 1999-03-02 ES ES99909758T patent/ES2281960T3/es not_active Expired - Lifetime
- 1999-03-02 AU AU28894/99A patent/AU762404B2/en not_active Ceased
- 1999-03-02 WO PCT/US1999/004605 patent/WO1999045025A1/en not_active Ceased
- 1999-03-02 US US09/260,078 patent/US6172110B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK1068219T3 (da) | 2007-04-30 |
| AU2889499A (en) | 1999-09-20 |
| NZ506623A (en) | 2002-10-25 |
| CA2322868C (en) | 2009-02-03 |
| JP2002505337A (ja) | 2002-02-19 |
| CA2322868A1 (en) | 1999-09-10 |
| PT1068219E (pt) | 2007-03-30 |
| EP1068219B1 (en) | 2006-12-20 |
| EP1068219A4 (en) | 2005-05-25 |
| DE69934486T2 (de) | 2007-10-04 |
| WO1999045025A1 (en) | 1999-09-10 |
| DE69934486D1 (de) | 2007-02-01 |
| EP1068219A1 (en) | 2001-01-17 |
| ES2281960T3 (es) | 2007-10-01 |
| AU762404B2 (en) | 2003-06-26 |
| US6172110B1 (en) | 2001-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69934486D1 (de) | Acylierte betulin- und dihydrobetulinderivate, ihre herstellung und verwendung | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| IL133623A0 (en) | Antithrombotic agents | |
| EP0999834A4 (en) | ANTITHROMOSIS | |
| DK0889876T3 (da) | Meta-substituerede phenylensulfonamidderivater | |
| DE69931393D1 (de) | Antithrombotische amide | |
| NO20012977D0 (no) | N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet | |
| EE03869B1 (et) | Sulfiinhappe derivaadid, nende valmistamine ja kasutamine | |
| AP2002002637A0 (en) | Novel piperazine | |
| TR199800436A2 (xx) | Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�. | |
| ATE292634T1 (de) | Inhibitoren der alpha-l beta-2 vermittelten zelladhäsion | |
| ES2173477T3 (es) | Derivados de tetrahidronaftaleno y su utilizacion terapeutica. | |
| TR199802060T2 (xx) | Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�. | |
| TR199900486T2 (xx) | Aziniloksi ve fenoksi-diaril-karbonasit t�revleri. | |
| DK0765320T3 (da) | Benzimidazolonderivater med central dopaminerg aktivitet | |
| WO2004028455A3 (en) | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof | |
| DK132188D0 (da) | Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika | |
| AP2001002306A0 (en) | Bridged piperazine derivatives. | |
| FI970469A0 (fi) | Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus | |
| IT1256320B (it) | Derivati eterociclici | |
| ATE308540T1 (de) | Antithrombosemittel | |
| TR199700735T1 (xx) | �ste�e g�re azt,DD1 ya da DDC ile birlikte ters transkritaz inhibit�r� 3T ve HIV proteaz inhibit�r� indinavirin kullan�lmas�yla HIV enfeksiyoun i�in bir arada terapi. | |
| HRP20010885B1 (en) | Ethanesulfonyl-piperidine derivatives | |
| UA41350C2 (uk) | Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі | |
| NO980058L (no) | Opthalmiske preparater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1068219 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |